Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty")

被引：22

作者：

Dengler, TJ ^{[1
]}

Katus, HA ^{[1
]}

机构：

[1] Heidelberg Univ, Internal Med Clin 3, Dept Cardiol Angiol & Pneumol, D-69115 Heidelberg, Germany

来源：

HERZ | 2002年 / 27卷 / 07期

关键词：

myocardial infarction; stem cell; cell transplantation; cellular cardiomyoplasty;

D O I：

10.1007/s00059-002-2412-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Myocardial infarction is the leading cause of heart failure in developed countries, because even the advanced therapeutic measures of today are usually not sufficient to prevent left ventricular remodeling as they fall short of actual replacement of necrotic cardiac myocytes. Recent new insights into stem cell biology have changed our understanding of regenerative activities in the infarcted heart and have raised considerable hopes for novel therapeutic approaches aimed at cardiac myocyte replacement/regeneration through cell transplantation ("cellular cardiomyoplasty"). Cell-Based Therapeutic Concepts: This review summarizes our present understanding of physiological stem cell/precursor cell mobilization to the infarcted heart and discusses the main therapeutic concepts for cell-based regeneration of myocardial infarction (adult/embryonic stem cells, skeletal myoblasts, endothelial precursors and others), including a brief over view of ongoing clinical trials. Finally, a short list of central clinical and research goals is provided, which should be addressed by stringently designed patient trials.

引用

页码：598 / 610

页数：13

共 57 条

[11] 2-7
[12] Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration
Condorelli, G
Borello, U
De Angelis, L
Latronico, M
Sirabella, D
Coletta, M
Galli, R
Balconi, G
Follenzi, A
Frati, G
De Angelis, MGC
Gioglio, L
Amuchastegui, S
Adorini, L
Naldini, L
Vescovi, A
Dejana, E
Cossu, G
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) : 10733 - 10738
[13] Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation
Crosby, JR
Kaminski, WE
Schatteman, G
Martin, PJ
Raines, EW
Seifert, RA
Bowen-Pope, DF
[J]. CIRCULATION RESEARCH, 2000, 87 (09) : 728 - 730
[14] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
Dimmeler, S
Aicher, A
Vasa, M
Mildner-Rihm, C
Adler, K
Tiemann, M
Rütten, H
Fichtlscherer, S
Martin, H
Zeiher, AM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 391 - 397
[15] Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning
Fändrich, F
Lin, XB
Chai, GX
Schulze, M
Ganten, D
Bader, M
Holle, J
Huang, DS
Parwaresch, R
Zavazava, N
Binas, B
[J]. NATURE MEDICINE, 2002, 8 (02) : 171 - 178
[16] Goodell MA, 2001, ANN NY ACAD SCI, V938, P208
[17] The role of stem cells in skeletal and cardiac muscle repair
Grounds, MD
White, JD
Rosenthal, N
Bogoyevitch, MA
[J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (05) : 589 - 610
[18] Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand
Heissig, B
Hattori, K
Dias, S
Friedrich, M
Ferris, B
Hackett, NR
Crystal, RG
Besmer, P
Lyden, D
Moore, MAS
Werb, Z
Rafii, S
[J]. CELL, 2002, 109 (05) : 625 - 637
[19] Indispensable tools: embryonic stem cells yield insights into the human heart
Hescheler, J
Fleischmann, BK
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 363 - 364
[20] Hematopoietic vascular and cardiac fates of bone marrow-derived stem cells
Hirschi, KK
Goodell, MA
[J]. GENE THERAPY, 2002, 9 (10) : 648 - 652

← 1 2 3 4 5 6 →